LATEST PRESS RELEASES

Red Light Holland Signs Definitive Agreement with Mera Life Sciences and Files Annual Financial Statements

Toronto, Ontario--(Newsfile Corp. - July 30, 2021) - Red Light Holland Corp. (CSE: TRIP) (FSE: 4YX) (OTC Pink: TRUFF) ("Red Light Holland"), an Ontario-based corporation engaged in the production, growth and sale of a premium brand of magic truffles, is pleased to announce that its financial results for the year ended March 31, 2021 ("FY2... Read More...

Novamind Opens 5th Clinic Location Specialized in Integrative Psychiatry for Patients with Treatment-Resistant Conditions

Company executes organic growth mandate, on track to open four new clinics by Q3 2021TORONTO, ON / ACCESSWIRE / July 29, 2021 / Novamind Inc. (CSE:NM)(OTC PINK:NVMDF)(FSE:HN2) ("Novamind"), a leading mental health company specialized in psychedelic medicine, is pleased to announce that it has completed the construction of a new clinic foc... Read More...

Numinus Wellness Closes Q3 2021 With $63.2 Million Cash Position, Lab and Trial Advances, and Strategic Expansion into Psychedelic Neurology

VANCOUVER, BC, July 29, 2021 - Numinus Wellness Inc. ("Numinus") (TSXV: NUMI), a mental health care company advancing innovative treatments and safe, evidence-based psychedelic-assisted therapies, today announced its fiscal third quarter results ended May 31, 2021. In the third quarter, Numinus maintained a healthy cash position, achieve... Read More...

The World’s Premiere Psychedelic and Wellness Event

As a lifelong advocate of holistic health, Aubrey is most passionate about raising awareness for the benefits of psychedelic medicine. "Psychedelic medicines have been an inexorable part of my story for the last 22 years. I'm looking forward to sharing more of my story with everyone at the Meet Delic event," stated Marcus. The experient... Read More...

Entheon Biomedical Further Strengthens Advisory Board with Appointment of Dr. Andy Greenshaw

Vancouver, British Columbia--(Newsfile Corp. - July 28, 2021) - Entheon Biomedical Corp. (CSE: ENBI) (OTCQB: ENTBF) (FSE: 1XU1) ("Entheon" or the "Company"), a biotechnology company focused on developing psychedelic medicines to treat addiction, is pleased to announce the addition of Dr. Andrew (Andy) Greenshaw, Professor of Psychiatry an... Read More...

Cybin Announces Size and Pricing of Previously Announced Overnight Marketed Public Offering of Common Shares

NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATESTORONTO, July 28, 2021--(BUSINESS WIRE)--Cybin Inc. (NEO: CYBN) (OTCQB: CLXPF) ("Cybin" or the "Company"), a biotechnology company focused on progressing psychedelic therapeutics, announced today the pricing of its previously announced overnight market... Read More...

Field Trip Health Ltd. to Commence Trading on the NASDAQ on July 29, 2021 Under the Symbol FTRP

TORONTO, July 27, 2021 -- Field Trip Health Ltd. (TSX: FTRP; FTRP.WT; OTCQX: FTRPF) ("Field Trip" or the “Company”), a global leader in the development and delivery of psychedelic therapies, announced today that it has received final approval from The NASDAQ Stock Market LLC (“NASDAQ”) to list its common shares on the NASDAQ Global Select... Read More...

Silo Pharma Awarded Notice of Allowance from United States Patent and Trademark Office for Homing Peptide Patent

Central Nervous System Homing Peptide under development to deliver Psychedelics including Psilocybin Englewood Cliffs NJ, July 27, 2021 -- Silo Pharma, Inc. (OTCQB:SILO), a development-stage biopharmaceutical company focused on the use of psychedelics as a therapeutic, today announcedthat the United States Patent Office has issued a notic... Read More...

MINDCURE Launches Second Stage of Manufacturing Synthetic Ibogaine for Use in Psychedelic Clinical Research

MINDCURE's pharmaceutical grade ibogaine would provide researchers access to a sustainable, high-quality, reliable, and consistent supply of the psychedelic drug. VANCOUVER, BC, July 27, 2021 - Mind Cure Health Inc. (CSE: MCUR) (OTCQB: MCURF) (FRA: 6MH) ("MINDCURE"), a leader in advanced proprietary technology and research for psychedelic... Read More...

Allied Corp Commends the Colombian Authorities for Approving the Export of Dried Cannabis Flower From Colombia

KELOWNA, British Columbia, July 26, 2021 -- Allied Corp. ("Allied" or the “Company”) (OTCQB: ALID) an international medical company focused on creating and providing health solutions to address today’s medical mental health issues is pleased to commend the recent announcement made by the Colombian authorities allowing for the export of dr... Read More...

Field Trip Health Ltd. Obtains Conditional Approval to List on Nasdaq Under the Symbol “FTRP”

TORONTO, July 23, 2021 -- Field Trip Health Ltd. (TSX: FTRP; FTRP.WT; OTCQX: FTRPF) ("Field Trip" or the “Company”), a global leader in the development and delivery of psychedelic therapies, announced today that it has received conditional approval from The NASDAQ Stock Market LLC (“NASDAQ”) to list its issued and outstanding common share... Read More...

Meet DELIC, the Premiere Psychedelic and Wellness Edutainment Event and Expo for Newcomers and Veteran Psychonauts, Announces Initial Business Speaker Lineup

Leading Business and Entrepreneurial Voices Include Itefayo Harvey, Dina Burkitbayeva, Matt Zemon, Martin Tobias, George Goldsmith, Mark Goldfogel, Nanea Reeves, Katya Malievskaia, Dr. Jeff Chen, Ronan Levy, Jennifer Pereira, Barbara Branaman and Many Others to Take Part in First of its Kind Las Vegas Event November 6-7, 2021 Two-Day Exp... Read More...

Novamind Has Applied to Have its Common Shares Posted for Trading on the OTCQB in the United States

Aims to increase visibility and facilitate investment for United States investorsTORONTO, ON / ACCESSWIRE / July 21, 2021 /Novamind Inc. (CSE:NM)(OTC PINK:NVMDF)(FSE:HN2) ("Novamind"), a leading mental health company specialized in psychedelic medicine, is pleased to announce that it has submitted its application to have its common shares... Read More...

PharmaTher Expands Psychedelic Patent Portfolio with Filing of U.S. Patent Application for Novel Ketamine Formulation

Strengthens position to become a leader in the intradermal delivery of FDA prescription-based ketamine productsSupports commercializing novel uses and delivery methods of psychedelics TORONTO, July 21, 2021 -- PharmaTher Holdings Ltd. (the “Company” or “PharmaTher”) (OTCQB: PHRRF) (CSE: PHRM), a clinical-stage psychedelics biotech company... Read More...

Mydecine Expands Portfolio of Novel Molecules Filing New Patent for MDMA-like Compounds

DENVER, July 21, 2021 -- Mydecine Innovations Group (NEO: MYCO) (OTC: MYCOF) (FSE: 0NFA) (“Mydecine” or the “Company”), an emerging biopharma and life sciences company committed to the research, development, and acceptance of alternative nature-sourced medicine for mainstream use, today announced that the Company has filed a new patent fo... Read More...

Red Light Holland Expected Merger Partner Creso Pharma Completes Acquisition of Halucenex Life Sciences Inc

Halucenex a key strategic asset for proposed merger between Red Light Holland and Creso Pharma to create The HighBrid LabToronto, Ontario--(Newsfile Corp. - July 15, 2021) - Red Light Holland Corp. (CSE: TRIP) (FSE: 4YX) (OTC Pink: TRUFF) ("Red Light Holland" or the "Company"), an Ontario-based corporation engaged in the production, growt... Read More...

Pure Extracts Signs Purchase Order with Private Saskatchewan Cannabis Distributor

VANCOUVER, British Columbia, July 15, 2021 -- Pure Extracts Technologies Corp. (CSE: PULL) (OTC: PRXTF) (XFRA: A2QJAJ) (“Pure Extracts” or the “Company”), a plant-based extraction company focused on cannabis, hemp, functional mushrooms and the rapidly emerging psychedelic sector, is pleased to announce that its wholly-owned subsidiary, Pu... Read More...

Red Light Holland Sells Approximately 350,000 Grams of Magic Truffles and Increases Points of Sale for iMicrodose Packs to Six More Smart Shops

Significant increase in number of points of sale for iMicrodose Packs now in 30 Smart Shops (including Brick and Mortar stores and online shops) plus (approximately) 350,000 grams of packaged magic truffles sold from the Red Light Holland Farm in Horst, the NetherlandsToronto, Ontario--(Newsfile Corp. - July 13, 2021) - Red Light Holland ... Read More...

Optimi Health Joins First Psychedelic Exchange Traded Fund

VANCOUVER, British Columbia, July 13, 2021 -- Optimi Health Corp. (CSE: OPTI) (OTC: OPTHF) (FRA: 8BN) (“Optimi” or the “Company”), a vertically integrated developer of mushroom products is pleased to announce its inclusion in the first psychedelics Exchange Traded Fund (“ETF”) (NEO: PSYK). The ETF began trading on the Neo Exchange as of J... Read More...

Lobe Sciences Appoints Gilberto Jesús Mendoza, President of the World Boxing Association, to Advisory Board

Vancouver, British Columbia--(Newsfile Corp. - July 13, 2021) - Lobe Sciences Ltd. (CSE: LOBE) (OTC Pink: GTSIF) ("Lobe" or the "Company") is pleased to announce the appointment of Gilberto Jesús Mendoza, President of the World Boxing Association, to its Advisory Board.Philip Young, CEO and Director of Lobe stated, "We are privileged to w... Read More...

Pure Extracts Submits Natural Health Product Licence Application for Blended Functional Mushroom Product

VANCOUVER, British Columbia, July 13, 2021 -- Pure Extracts Technologies Corp. (CSE: PULL) (OTC: PRXTF) (XFRA: A2QJAJ) (“Pure Extracts” or the “Company”), a plant-based extraction company focused on cannabis, hemp, functional mushrooms and the rapidly emerging psychedelic sector, is pleased to announce that its wholly-owned subsidiary, Pu... Read More...

MINDCURE Announces Filing of U.S. Provisional Patent Applications for Company’s First Fully Synthetic Routes to Create an Ibogaine Psychedelic Compound

The company's pharmaceutical grade ibogaine would provide researchers access to a sustainable, high-quality, reliable, and consistent supply of the psychedelic drug, ibogaine. VANCOUVER, BC, July 13, 2021 - Mind Cure Health Inc. (CSE: MCUR) (OTCQB: MCURF) (FRA: 6MH) ("MINDCURE" or the "Company"), a leader in advanced proprietary technolo... Read More...

MINDCURE Adopts Advance Notice Policy

VANCOUVER, BC, July 12, 2021 - Mind Cure Health Inc. (CSE: MCUR) (OTCQB: MCURF) (FRA: 6MH) ("MINDCURE" or the "Company"), a leader in advanced proprietary technology and research for psychedelics, is pleased to announce that the Company's board of directors (the "Board") has adopted a policy that requires advance notice to the Company wit... Read More...